Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 10/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 7/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | F9 | P00740 | 2/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14101527 | 0.97 | S1PR5 (0.40) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101463 | 0.97 | S1PR5 (0.40) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101456 | 0.97 | S1PR5 (0.40) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101530 | 0.96 | S1PR5 (0.39) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101535 | 0.96 | ESR1 (0.39) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101434 | 0.96 | GSTP1 (0.43) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101468 | 0.94 | S1PR5 (0.36) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101529 | 0.94 | S1PR5 (0.41) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101441 | 0.93 | S1PR5 (0.42) | GSTP1ESR1ESR2S1PR5S1PR4 | |
| SCHEMBL14101540 | 0.92 | S1PR5 (0.40) | GSTP1ESR1ESR2S1PR5S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080166594-A1 | BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-10 | — | — | US | disclosed |
| US-20080166594-A1 | BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080166594-A1 | BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME | CYBA, BPNT1, TYR | GSTP1 731/4885ESR1 266/4885ESR2 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.